亚太地区血液成分市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按产品、适应症(肾脏疾病、血液疾病、神经疾病、自身免疫性疾病和其他适应症)、程序和地理细分

市场快照

Asia Pacific Apheresis Market_1
Study Period: 2018 - 2026
Base Year: 2021
CAGR:

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期间(2019-2024 年),所研究的亚太地区血液成分市场预计将以 11.26% 的复合年增长率增长。

导致亚太单采市场增长的主要因素是疾病负担增加、对血液成分的需求增加以及相关的安全性和新单采技术开发中的技术进步。然而,与单采程序相关的高资本投资和成本等因素预计将抑制市场。

单采现在已成为治疗多种复杂免疫疾病的流行模式,亚太地区治疗性单采的情况发生了显着变化。随着疾病和事故案件数量的增加,以及技术进步,预计所研究的市场将在预测期内出现增长。此外,越来越多的政府举措、献血营以及对医疗保健意识的提高是所研究市场增长的原因。单采技术是昂贵的。它在技术和医学上也很苛刻。

报告范围

单采术是一种医疗技术,其中个体(供体或患者)的血液通过分离特定成分并将其余血液返回循环系统的装置。这是一种体外治疗。

By Product
Devices
Disposables
By Indication
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Other Indications
By Procedure
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Other Procedures
Geography
China
Japan
India
Australia
South Korea
Rest of Asia Pacific

Report scope can be customized per your requirements. Click here.

主要市场趋势

神经系统疾病有望在适应症领域以高复合年增长率增长

亚洲的神经系统疾病模式与西方国家基本相似,脑血管疾病、头痛和癫痫发作是最常见的主诉。

亚洲特有的疾病特征包括青年中风比例高,主要来自过早的动脉粥样硬化,颅内与颅外疾病的高发病率,视神经脊髓炎的相对常见性和多发性硬化症(MS)的视脊髓形式,性相关性肌张力障碍和帕金森病的高发病率。血浆置换是公认的治疗程序之一,通常用于许多神经性自身免疫性疾病。人们认为,血浆交换的作用是通过消除包括自身抗体、补体成分和细胞因子在内的特征性炎症介质而发生的。大多数神经系统疾病的治疗都受益于治疗性单采术,

Asia Pacific Apheresis Market_2

竞争格局

亚太地区的血液成分市场竞争适度,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者在血液成分市场上占据主导地位。随着亚太地区疾病流行率的增加,预计单采术的使用量将增加,因此预计很少有其他参与者进入市场。市场上的一些主要参与者包括 Asahi Kasei Corporation、B. Braun Melsungen AG、Cerus Corporation、Kaneka Corporation 和 Terumo Corporation 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Disease Burden in Asia

      2. 4.2.2 Rise in Demand for Blood Components and Associated Safety

      3. 4.2.3 Technological Advancement in the Development of New Apheresis Techniques

    3. 4.3 Market Restraints

      1. 4.3.1 High Capital Investment and Cost Associated with Apheresis Procedures

      2. 4.3.2 Risk of Blood Contamination

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Devices

      2. 5.1.2 Disposables

    2. 5.2 By Indication

      1. 5.2.1 Renal Disorders

      2. 5.2.2 Hematological Disorders

      3. 5.2.3 Neurological Disorders

      4. 5.2.4 Autoimmune Disorders

      5. 5.2.5 Other Indications

    3. 5.3 By Procedure

      1. 5.3.1 Plasmapheresis

      2. 5.3.2 Plateletpheresis

      3. 5.3.3 Erythrocytapheresis

      4. 5.3.4 Leukapheresis

      5. 5.3.5 Other Procedures

    4. 5.4 Geography

      1. 5.4.1 China

      2. 5.4.2 Japan

      3. 5.4.3 India

      4. 5.4.4 Australia

      5. 5.4.5 South Korea

      6. 5.4.6 Rest of Asia Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Asahi Kasei Corporation

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Cerus Corporation

      4. 6.1.4 Kaneka Corporation

      5. 6.1.5 Terumo Corporation

      6. 6.1.6 Fresenius SE & Co. KGaA

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia Pacific Apheresis Market market is studied from 2018 - 2026.

The Asia Pacific Apheresis Market is valued at 11.26% in 2018.

Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation, Terumo Corporation are the major companies operating in Asia Pacific Apheresis Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!